VIVUS Press Releases

Date Title Links
Toggle Summary VIVUS Announces Date of 2016 Second Quarter Business Update and Financial Results Teleconference
MOUNTAIN VIEW, CA -- (Marketwired) -- 07/26/16 -- VIVUS, Inc. ( NASDAQ : VVUS) today announced that it will report financial results and provide a business update for the second quarter of 2016 after the NASDAQ Market closes on Thursday, August 4, 2016 .
View HTML
Toggle Summary VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation
Majority of VIVUS' Claim Constructions Adopted in Ruling
View HTML
Toggle Summary VIVUS to Extend Return Date of STENDRA Commercial Rights
VIVUS and Auxilium Agree to Extend the STENDRA(R) (avanafil) License Agreement Through August 31, 2016
View HTML
Toggle Summary Vivus Reports 2016 First Quarter Financial Results
Management to Review Results and Provide Business Update in Conference Call Today at 4:30 p.m. Eastern Time
View HTML
Toggle Summary VIVUS Announces Date of 2016 First Quarter Business Update and Financial Results Teleconference
MOUNTAIN VIEW, CA -- (Marketwired) -- 04/19/16 -- VIVUS , Inc.  ( NASDAQ : VVUS) today announced that it will report financial results and provide a business update for the first quarter of 2016 after the NASDAQ Market closes on Tuesday, May 3, 2016. The company will conduct a conference call and
View HTML
Toggle Summary VIVUS Reports Fourth Quarter and Year-End 2015 Financial Results
Management to Review Results and Provide Business Update in Conference Call Today at 4:30 p.m. Eastern Time
View HTML
Toggle Summary VIVUS Announces Date of Fourth Quarter 2015 Update and Financial Results Teleconference
MOUNTAIN VIEW, CA -- (Marketwired) -- 02/29/16 -- VIVUS , Inc.  ( NASDAQ : VVUS) today announced that it will report financial results for the fourth quarter and year ended December 31, 2015 after the NASDAQ Market closes on Wednesday, March 9, 2016. The company will conduct a conference call and
View HTML
Toggle Summary VIVUS, Inc. Announces Intent to Reacquire U.S. and Canadian Rights for Stendra(R) (Avanafil)
MOUNTAIN VIEW, CA -- (Marketwired) -- 12/31/15 -- VIVUS , Inc.  ( NASDAQ : VVUS)  (the "Company"), announced today that it has been notified by Auxilium Pharmaceuticals, Inc. , a subsidiary of Endo International, plc., of Auxilium's intention to return the U.S.
View HTML
Toggle Summary A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss
New Survey Finds Good Intentions Don't Always Equal Results or Change in Habits
View HTML
Toggle Summary VIVUS Reports Third Quarter 2015 Financial Results
MOUNTAIN VIEW, CA -- (Marketwired) -- 11/04/15 -- VIVUS, Inc. ( NASDAQ : VVUS) (the "Company"), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health, today provided a business update and reported its
View HTML